Corneal Densitometry Changes With Adenoviral SEI

Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Corneal Disease Adenoviridae Infections Corneal Diseases DNA Virus Infections Eye Diseases Infections Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

INMC

Abu Dhabi, 46266, United Arab Emirates

About this study

first group of patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.S econd group underwent transepithelial PTK for subepithelial infiltrates. Baseline and post-treatment full ophthalmic examination was done.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adenoviral SEI

Exclusion criteria

Other corneal diseases

Treatment and study plan

Tacrolimus ointment

Drug

Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.

Other names: Protopic ointment

phototherapeutic keratectomy

Procedure

Patients underwent transepithelial PTK for subepithelial infiltrates.

Primary outcomes

changes of corneal densitometry

Time frame: 6 months

Sub epithelial infiltrates was examined with the densitometry programme of the Pentacam (Fa. Oculus,Weimar, Germany)

Sponsors and collaborators

Lead sponsor

Benha University

Other

Registry information

Official study title

Corneal Densitometry Changes With Adenoviral Keratoconjunctivitis Sub Epithelial Infiltrates

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Feb 13, 2020
Registry last updated: May 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed